These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3878806)

  • 1. Ontogeny of the transplantation immunity of mice for rejecting ascitic allogeneic tumors.
    Ando K; Hasegawa T; Nakashima I; Mizoguchi K; Isobe K; Nagase F; Kawashima K; Kato N; Ohashi K
    Dev Comp Immunol; 1985; 9(4):701-8. PubMed ID: 3878806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune reactivity of allogeneically pregnant mice to paternal MHC antigens on fetal and placental cells assessed by second set rejection of ascites tumor cells.
    Saito M; Nakashima I; Mizoguchi K; Isobe K; Nagase F; Goto S; Tomoda Y
    J Reprod Immunol; 1985 Nov; 8(2-3):139-51. PubMed ID: 4093908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OK-432-mediated augmentation of antitumor immunity and generation of cytotoxic T lymphocytes.
    Ujiie T
    Jpn J Exp Med; 1987 Apr; 57(2):103-15. PubMed ID: 3499533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mode of alloantibody-mediated blockade of allo-sensitization for tumor allograft rejection.
    Lai H; Hasegawa Y; Mizoguchi K; Yoshida T; Isobe K; Shimokata K; Kawashima K; Nakashima I
    Immunobiology; 1989 Mar; 179(1):33-43. PubMed ID: 2786494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of high-grade tumor-specific immunity in a host using a cytotoxic T-lymphocyte clone specific for a stable tumor antigen on murine leukemia L1210.
    Rahman SM; Kawashima K; Nakashima I; Nagase F
    Cancer Res; 1988 Nov; 48(22):6450-4. PubMed ID: 3263189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression of afferent arc of the in vivo cytotoxic T-cell immunity by bacterial lipopolysaccharides.
    Mizoguchi K; Nakashima I; Hasegawa Y; Isobe K; Kato N; Shimokata K; Kawashima K; Nagase F; Ando K; Yoshida T
    Cell Immunol; 1985 Oct; 95(2):330-9. PubMed ID: 2931181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of host-dependent high-grade tumor-specific immunity through a novel mechanism triggered by the Lyt-2+ tumor-specific T cell clone (K7L) that induces temporal growth of L1210 leukemia-K7L-variant.
    Nagase F; Ueda K; Kawashima K; Jamshedur Rahman SM; Isobe K; Yoshida T; Hasegawa Y; Ando K; Iwamoto T; Nagura E
    J Immunol; 1987 Apr; 138(7):2359-65. PubMed ID: 2951438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation resistance of drug-treated allogeneic mice against murine lymphomas--II. Studies with various tumor-host combinations.
    Bonmassar A; Rivosecchi-Merletti P; Barzi A; Goldin A; Bonmassar E
    Int J Immunopharmacol; 1981; 3(4):391-9. PubMed ID: 7333720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune inhibition of allogeneic lymphoma cells in the peritoneal cavity of mice.
    Fioretti MC; Libarati M; Bonmassar E; Cudkowicz G
    Cancer Res; 1975 Jan; 35(1):30-6. PubMed ID: 1089042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance induction of alloreactivity by portal venous inoculation with allogeneic cells followed by the injection of cyclophosphamide. I. Specific suppression of alloreactive cytotoxic and delayed-type hypersensitivity responses as well as allograft rejection.
    Qian JH; Kokudo S; Sato S; Hamaoka T; Fujiwara H
    Transplantation; 1987 Apr; 43(4):538-43. PubMed ID: 3495052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and stimulatory cell type requirements for inducing class I major histocompatibility complex alloantigen-specific in vivo cytotoxic T cell immunity.
    Mizoguchi K; Nakashima I; Isobe K; Ando K; Nagase F; Kato N; Kawashima K; Shimokata K; Hasegawa Y
    Eur J Immunol; 1985 May; 15(5):487-94. PubMed ID: 3873341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-grade tumor-specific immunity induced by L1210 leukemia variants obtained from the culture of L1210 cells fused with Lesch-Nyhan fibroblasts.
    Kawashima K; Nagura E; Watanabe E; Mizoguchi K; Saga S; Isobe K; Nakashima I; Yamada K; Oikawa T; Kojima K
    Int J Cancer; 1983 Oct; 32(4):507-14. PubMed ID: 6618710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A possible site of in vivo action of cyclosporin A for transplantation immunity: comparative study with cyclophosphamide.
    Hasegawa Y; Isobe K; Nagase F; Shimokata K; Nakashima I
    Immunobiology; 1991 Nov; 183(5):408-17. PubMed ID: 1786989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biphasic radiation-sensitivity of the transplantation immunity for rejection of an allogeneic ascites tumor.
    Hasegawa Y; Nakashima I; Mizoguchi K; Nagase F; Isobe K; Shimokata K; Kawashima K; Ando K; Yoshida T; Iwamoto T
    Immunobiology; 1988 May; 177(2):120-33. PubMed ID: 3042613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T killer cells play a role in allogeneic bone marrow graft rejection but not in hybrid resistance.
    Dennert G; Anderson CG; Warner J
    J Immunol; 1985 Dec; 135(6):3729-34. PubMed ID: 3905963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation by OK-432 of generation of culture-induced killer cells.
    Ujiie T
    Jpn J Exp Med; 1987 Jun; 57(3):153-61. PubMed ID: 3682231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ethylene glycol monomethyl (EGME) and monoethyl (EGEE) ethers on the immunocompetence of allogeneic and syngeneic mice bearing L1210 mouse leukemia.
    Houchens DP; Ovejera AA; Niemeier RW
    Environ Health Perspect; 1984 Aug; 57():113-8. PubMed ID: 6499794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The response of C3H mice to an L1210 tumor allograft.
    Nevalainen DE
    Res Commun Chem Pathol Pharmacol; 1974 Apr; 7(4):771-4. PubMed ID: 4828768
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunological enhancement of leukemia L1210 by Corynebacterium parvum in allogeneic mice.
    Berd DA; Mitchell MS
    Cancer Res; 1976 Nov; 36(11 Pt 1):4119-24. PubMed ID: 975053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.